Diabetes Drug Stops Prostate Cancer From Coming Back

A diabetes drug may hold the key to preventing prostate cancer relapse. Scientists discovered that prostate cancer patients with diabetes who took PPARy-targeting drugs stayed cancer-free during follow-up. The drug, pioglitazone, appears to…

Continue Reading